JUSTERA HEALTH LTD. Financials Justera Health Ltd.
Equities
VTAL
CA4821391022
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.005 CAD | 0.00% |
|
0.00% | -66.67% |
| Mar. 22 | Justera Health Ltd. Announces Board Changes | CI |
| 2023 | Justera Health Ltd. Announces Chief Executive Officer Changes | CI |
Valuation
| Fiscal Period: December | 2021 | 2022 |
|---|---|---|
| Capitalization 1 | 8.328 | 3.563 |
| Enterprise Value (EV) 1 | 8.241 | 3.246 |
| P/E ratio | -0.7 x | -0.5 x |
| Yield | - | - |
| Capitalization / Revenue | 425,055 x | 242,514 x |
| EV / Revenue | 420,616 x | 220,955 x |
| EV / EBITDA | -2,540,521 x | -949,023 x |
| EV / FCF | 43,342,662 x | 28,845,493 x |
| FCF Yield | 0% | 0% |
| Price to Book | 9.84 x | 2.77 x |
| Nbr of stocks (in thousands) | 41,639 | 118,772 |
| Reference price 2 | 0.2000 | 0.0300 |
| Announcement Date | 5/2/22 | 5/1/23 |
1CAD in Million2CAD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| Net sales | - | - | 19.59 | 14.69 |
| EBITDA | - | - | -3.244 | -3.421 |
| EBIT 1 | -0.0524 | -0.0723 | -3.556 | -3.919 |
| Operating Margin | - | - | -18.15% | -26.67% |
| Earnings before Tax (EBT) 1 | -0.0524 | -0.0723 | -9.375 | -5.252 |
| Net income 1 | -0.0524 | -0.0723 | -9.375 | -5.252 |
| Net margin | - | - | -47.85% | -35.74% |
| EPS 2 | -0.0107 | -0.0148 | -0.2869 | -0.0602 |
| Free Cash Flow | - | -0.0364 | 0.1901 | 0.1125 |
| FCF margin | - | - | 0.97% | 0.77% |
| FCF Conversion (EBITDA) | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - |
| Dividend per Share | - | - | - | - |
| Announcement Date | 4/30/21 | 4/30/21 | 5/2/22 | 5/1/23 |
1CAD in Million2CAD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| Net Debt 1 | 0.07 | 0.13 | - | - |
| Net Cash position 1 | - | - | 0.09 | 0.32 |
| Leverage (Debt/EBITDA) | - | - | - | - |
| Free Cash Flow | - | -0.04 | 0.19 | 0.11 |
| ROE (net income / shareholders' equity) | - | 50.8% | -2,809% | -493% |
| ROA (Net income/ Total Assets) | - | -141,275% | -90.9% | -49.7% |
| Assets 1 | - | 0.000051 | 10.31 | 10.56 |
| Book Value Per Share 2 | -0.0200 | -0.0400 | 0.0200 | 0.0100 |
| Cash Flow per Share 2 | 0 | 0 | 0 | 0 |
| Capex | - | - | 0.74 | 0.12 |
| Capex / Sales | - | - | 3.76% | 0.8% |
| Announcement Date | 4/30/21 | 4/30/21 | 5/2/22 | 5/1/23 |
1CAD in Million2CAD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -66.67% | 588K | |
| -4.77% | 182B | |
| +4.10% | 114B | |
| -3.85% | 67.76B | |
| +5.19% | 51.91B | |
| +5.54% | 43.23B | |
| +6.07% | 41.07B | |
| +23.81% | 32.07B | |
| +15.86% | 25B | |
| -5.06% | 24.35B |
- Stock Market
- Equities
- VTAL Stock
- Financials Justera Health Ltd.
